ERBB2 and triple-negative breast carcinoma: A better understanding of the biology has led to overcome the historical classification in three subgroups hormone receptor-positive (HR +), human epidermal growth factor receptor 2 overexpressed or amplified (HER2 +) and triple-negative breast cancer (TNBC), defined by the lack of HRs and HER2 overexpression or amplification.